Paleo Opens New Facility in Belgium for Animal-Free Heme, Reveals Expansion Plans for 2024
On the back of its successful €12 million funding round last year, biotech company Paleo has opened a new pilot-scale facility in Leven, Belgium, at the Bio-Incubator Leuven. The company, which specializes in developing proteins via precision fermentation, aims to use the new laboratory facilities to accelerate the production and commercialization of its flagship product, animal-free heme. Speaking to vegconomist, the company outlined its plans for 2024, including making significant progress in bringing its products to market and preparing for a Series B investment round. Last year, the company opened an office in Singapore to serve future activities in the Asia-Pacific region, where market approval for novel foods takes less time than in Europe. Expansion of the leadership team As part of the 2024 strategy, Paleo …